Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2008
11/06/2008US20080275099 Solid Forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime
11/06/2008US20080275067 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275013 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
11/06/2008US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080274999 Cosmetics; low molecular weight; therapy for osteoarthritis
11/06/2008US20080274945 Infant Nutrition With Protease Inhibitor
11/06/2008US20080274205 Ena Mineral Bioactive Solution, Manufacturing Method Thereof and Its Application for the Osteoporosis Prevention
11/06/2008US20080274204 For bath/body cosmetics; psoriasis, psoriatic arthritis, rheumatoid arthritis, osteoarthritis
11/06/2008US20080274186 NELL-1 enhanced bone mineralization
11/06/2008US20080274185 Inducing angiogenesis enhancing implant success of adult mesenchymal cell scaffolds
11/06/2008US20080274157 Removing cellular debris, proteoglycans and minced cartilage; drilling a cylindrical hole at a site of a cartilage defect; placing a preshaped osteochondral plug with minced cartilage in fibrinogen thrombin solution in the gap between the plug and a side wall; forming new bone matrix
11/06/2008US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders
11/06/2008CA2685099A1 Antibodies against ramp3
11/06/2008CA2683488A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/05/2008EP1986678A1 Dissolution aids for oral peptide delivery comprising a biguanide
11/05/2008EP1986657A2 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1986566A1 Accelerating agent of calcium absorption
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1341811B9 Orally ingestible preparation of mistletoe lectins and method
11/05/2008CN101300025A Use of calcitonin for the treatment of RA
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101298466A Oleanolic acid derivate, preparation and use thereof
11/05/2008CN101297990A Regimen using padauk and health-preserving pillow
11/05/2008CN101297946A Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof
11/05/2008CN101297943A Medicinal liquor for strengthening bones and muscles and treating rheumatism
11/05/2008CN101297937A Chinese patent medicine formulation for treating cervical vertebra disease and preparation thereof
11/05/2008CN101297908A Liver-tonifying kidney-boosting medicinal liquor
11/05/2008CN101297895A Pure Chinese medicinal liquor for treating bone regeneration
11/05/2008CN101297891A Medicinal liquor for activating blood circulation, removing stasis and strengthening spleen
11/05/2008CN101297868A Medicament for preventing and treating osteoporosis and preparation thereof
11/05/2008CN101297854A Plaster for curing lumbar and cervical vertebra diseases
11/05/2008CN101297853A Bone-melon extract injection and preparation thereof
11/05/2008CN101297841A Compound Tripterygium wilfordii multi-glycosides formulation for curing rheumatic disease and preparation method thereof
11/05/2008CN101297803A Novel medical use of osthole
11/05/2008CN101297790A Zaltoprofen sustained-release preparation and preparation thereof
11/05/2008CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent
11/05/2008CN100430055C Glassiness sosoloid contg. 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazol formic-acid and polyvinyl pyrrolidone and its prepn. method
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
11/04/2008US7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445776 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
10/2008
10/30/2008WO2008131154A2 Fibrin compositions containing strontium compounds
10/30/2008WO2008130172A1 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
10/30/2008WO2008129802A1 Agent for lowering serum uric acid level and food or drink with indication of lowering serum uric acid level
10/30/2008WO2008129624A1 Pyrazolopyridine-4-yl-pyrazolone derivative, addition salt thereof and phosphodiesterase inhibitor containing the same as active ingredient
10/30/2008WO2008128629A1 Novel use of hydroxytyrosol
10/30/2008WO2008128559A1 Method for providing a compound capable of interfering with a distorted chondrocyte phenotype
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008128342A1 Composition for enhancing bone formation
10/30/2008WO2008100635A8 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
10/30/2008WO2008087461B1 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
10/30/2008WO2008075206A3 Cell-matrix microspheres, methods for preparation and applications
10/30/2008WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/30/2008WO2008051496A3 Use of il-1 antagonists to treat gout and pseudogout
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide
10/30/2008US20080269267 Anticancer agents; rheumatic diseases; asthma; chronic obstructive pulmonary disease; neurodegenerative diseases; metabolic disorders
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269231 Phenazine Compounds and Use Thereof in Autoimmune and Inflammatory Disease
10/30/2008US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders
10/30/2008US20080269189 Method for Avoiding Edema in the Treatment or Prevention of Ppary-Responsive Diseases, Including Cancer
10/30/2008US20080269149 Adeno-associated virus (AAV); genetic engineering; parvoviruses; gene therapy; muscle delivery; glioblastoma; Parkinson's Disease
10/30/2008US20080269137 Compositions and methods for modulating the immune system
10/30/2008US20080269131 Protein kinase B ; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; cancer and arthritis
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080268064 fractioning blood to produce a blood component, shaping the cartilage defect to expose subchondral bone, microfracturing the subchondral bone, and applying the blood component to the microfractured subchondral bone
10/30/2008US20080268056 Injectable copolymer hydrogel useful for repairing vertebral compression fractures
10/30/2008US20080268053 Collagen carrier of therapeutic genetic material, and method
10/30/2008US20080268052 exhibits an enhanced rate of polymerization and enhanced microstructural and mechanical properties upon polymerization
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone
10/30/2008US20080268012 Extracted demineralized bone matrix having osteoinductive activity
10/30/2008US20080267999 Neoepitope detection of disease using protein arrays
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267950 Molecular determinants of myeloma bone disease and uses thereof
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008CA2720269A1 Composition for enhancing bone formation
10/30/2008CA2686820A1 Fibrin compositions containing strontium compounds
10/30/2008CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 820